The global Cholangiosarcoma Market is expanding as oncology centers increasingly adopt biomarker-guided treatment strategies and hospital-based care pathways for patients with complex bile duct cancers. According to Future Market Insights (FMI), the market is projected to grow from USD 1.8 billion in 2026 to USD 5.3 billion by 2036, registering an 11.5% CAGR during the forecast period. The...